ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0628

Factors Associated with Knee Osteoarthritis in an Outpatient HIV-1 Clinic over a 26 Year Interval

Benjamin Naovarat1, Francis Williams1, Jonathan Dau2, Marka Lyons3, Binh Nguyen4, Gloria Salazar3 and John Reveille5, 1The University of Texas McGovern Medical School, Houston, TX, 2Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3University of Texas Houston, McGovern Medical School, Division of Rheumatology and Clinical Immunogenetics, Houston, TX, 4The University of Texas-McGovern Medical School, Houston, TX, 5Department of Internal Medicine, University of Texas, Houston, TX

Meeting: ACR Convergence 2020

Keywords: Epidemiology, Infection, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: With the advent of combined antiretroviral therapy (cART), patients with HIV-1 began living longer and started to develop diseases associated with aging such as osteoarthritis (OA). This study examined the epidemiologic, clinical, and immunological data in patients with concomitant HIV-1 and knee OA.

Methods: We examined with knee OA treated at a HIV-1 outpatient clinic seen between 1994 and 2020. At baseline visit, demographic parameters, lymphocyte subsets, HIV-1 viral load, knee OA date of diagnosis, pertinent lab findings, knee radiographs, and relevant clinical information were collected. All patients met the American College of Rheumatology Classification Criteria for knee OA. Antiretroviral medications were categorized into protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors. Univariate and multivariate analyses were conducted that looked at age, BMI, ethnicity, gender, CD4 count, HIV viral load, antiretroviral medication use, and time of knee OA diagnosis on the risks of developing knee OA.

Results: Comparing the pre-HAART (1994-1997) to the era after the introduction of HAART (1998-2020), the frequency of DILS and reactive arthritis fell whereas the osteoarthritis, particularly of the knee, and carpal tunnel syndrome rose dramatically (Table 1). A total of 217 patients with HIV-1 infection and knee OA were identified out of  the 1671 patients referred to the HIV Rheumatology Clinic. Patients with knee OA were more likely to be female and to be black or Latino than white (Table 2). The knee OA patients were older  (average age of 51.1 [±9.1] years compared to 46.7 [±9.8] years in the non-knee OA group). In addition, knee OA patients had a greater body mass index (BMI-average of 32.8 [±7.9] compared to 28.5 [±6.6] in the non-knee OA group). Patients with knee OA were more likely to have CD4 >200 cells/μL at baseline than those with other diagnoses. Medication use with NRTI and integrase inhibitors respectively, were significantly associated with knee OA. However, on multivariable analysis, independent associations of CD4 count, HIV viral load, NRTI and integrase inhibitor usage were not observed. When stratifying antiretroviral usage into the categories of no therapy, mono-drug therapy, and multi-drug therapy, those on multidrug-therapy had higher odds of having knee OA that those on no therapy. However, in the multivariable analysis, this association was not independently observed. Moreover, between the period of 1994 and 2020, we noted an increase in the frequency of knee OA over time on both the univariable (p< 0.001) and multivariable analyses (p< 0.001).

Conclusion: To date, this is the largest cohort of concomitant HIV-1 and knee OA patients followed longitudinally to date. Our cohort confirmed the risk factors of BMI, age, ethnicity, and female gender as well as demonstrating that there is a relationship with CD4 >200 cells/μL and an increase in the frequency of knee OA diagnoses over the period 1994-2006, probably reflecting the longer survival of patients with HIV with effective treatment and factors associated with HIV treatment itself.

Table 1. Harris County HIV Rheumatology Clinic Distribution of Diagnoses in the Pre-and Post-HAART Eras

Table 2. Demographic and Clinical Parameters in HIV Rheumatology Patients with and without Knee OA


Disclosure: B. Naovarat, None; F. Williams, None; J. Dau, None; M. Lyons, None; B. Nguyen, None; G. Salazar, None; J. Reveille, Eli Lilly, 2, UCB, 5, Janssen, 2.

To cite this abstract in AMA style:

Naovarat B, Williams F, Dau J, Lyons M, Nguyen B, Salazar G, Reveille J. Factors Associated with Knee Osteoarthritis in an Outpatient HIV-1 Clinic over a 26 Year Interval [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/factors-associated-with-knee-osteoarthritis-in-an-outpatient-hiv-1-clinic-over-a-26-year-interval/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-knee-osteoarthritis-in-an-outpatient-hiv-1-clinic-over-a-26-year-interval/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology